HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation.

Abstract
Taxol, a first-line anti-tumour drug, has low effectiveness against colorectal cancer. Combination with other agents is an effective strategy to enhance Taxol cytotoxicity. Kanglaite injection is an extract from Coix lacryma-jobi seed and is usually combined with other agents to treat cancer. The aim of this study was to investigate the treatment effect of Taxol combined with Kanglaite on colorectal cancer cell lines. Kanglaite pretreatment followed by Taxol treatment was found to show the best synergism among all combination strategies. This combination also resulted in the smallest tumour volume in a Balb/c mice model. Kanglaite inhibited the expression of nuclear factor (NF)-κΒ and upregulated that of connexin 43, both of which sensitized cancer cells to Taxol. Moreover, Kanglaite increased many cellular variations caused by Taxol, including tubulin polymerization, caspase-3 cleavage, and upregulated expression of survivin and cyclin B1. These results suggest that Kanglaite pretreatment may increase the effect of Taxol on colorectal cancer.
AuthorsYijia Wang, Chunze Zhang, Shiwu Zhang, Zhenying Zhao, Jiawen Wang, Jiali Song, Yue Wang, Jun Liu, Shaobin Hou
JournalScientific reports (Sci Rep) Vol. 7 Issue 1 Pg. 1280 (04 28 2017) ISSN: 2045-2322 [Electronic] England
PMID28455529 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Connexin 43
  • Drugs, Chinese Herbal
  • NF-kappa B
  • Paclitaxel
  • kang-lai-te
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (administration & dosage, pharmacology)
  • Cell Line, Tumor
  • Colorectal Neoplasms (drug therapy)
  • Connexin 43 (biosynthesis)
  • Disease Models, Animal
  • Drug Synergism
  • Drugs, Chinese Herbal (administration & dosage, pharmacology)
  • Mice, Inbred BALB C
  • NF-kappa B (antagonists & inhibitors)
  • Paclitaxel (administration & dosage, pharmacology)
  • Treatment Outcome
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: